The increase of only SBS13 mutations in BRCA1/2-deficient breast cancers mirrors our observation that increased APOBEC-induced mutation is driven by higher rates of C-to-G substitutions in recombination-deficient yeast strains (Fig. 4B). This evidence concerns the gene BRCA1 and breast carcinoma.